SERPINE1 and cardiovascular disorder: The plasminogen activator inhibitor-1 (PAI-1) level is higher in DM2 and metabolic syndrome, whereby nature fucoxanthin functions as a thrombosis and fibrosis mediator, which explains its significant risk factor for macrovascular complications and cardiovascular diseases, particularly in patients with diabetes [152].